PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.944
https://www.valueinhealthjournal.com/article/S1098-3015(11)01083-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
423
First Page :
A170
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01083-7&doi=10.1016/j.jval.2011.02.944